Physician profile
Sandra J Lightner
NPI 1275148769
$1,317.70
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $30.34 · 2022: $132 · 2023: $404 · 2024: $751.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,156.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,155.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $376.86 | 2024 | Airsupra, Farxiga |
| Lilly USA, LLC | $145.99 | 2023-2024 | Zepbound, Amyvid, Mounjaro |
| Novo Nordisk INC | $126.69 | 2023-2024 | Ozempic, Rybelsus |
| Averitas Pharma INC. | $121.09 | 2023 | Qutenza |
| Mayne Pharma Commercial LLC | $119.93 | 2024 | |
| Abbvie INC. | $50.42 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $44.76 | 2022-2024 | Xifaxan |
| Biohaven Pharmaceutical Holding Company LTD. | $42.84 | 2022 | |
| Pfizer INC. | $41.03 | 2023-2024 | |
| Merz Pharmaceuticals, LLC | $33.25 | 2023 | Xeomin |
| Neurocrine Biosciences, INC. | $30.19 | 2024 | Ingrezza |
| Organon LLC | $24.68 | 2022 | |
| Merck Sharp & Dohme LLC | $23.54 | 2022 | |
| Kyowa Kirin, INC. | $21.79 | 2024 | Nourianz |
| Kowa Pharmaceuticals America, INC. | $19.66 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $18.02 | 2023 | Rexulti |
| Dynavax Technologies Corporation | $15.98 | 2021 | |
| Novartis Pharmaceuticals Corporation | $15.81 | 2023 | |
| Scilex Pharmaceuticals INC. | $15.78 | 2023 | Ztlido |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.03 | 2024 | Jardiance |
| Hologic Sales and Service, LLC | $14.36 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandra Lightner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.